US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

38.06

+0.18000.48%

Pre-market: 38.080.0243+0.06%07:15 EDT

Volume:114.36K

Turnover:4.36M

Market Cap:256.91M

PE:- -

High:38.28

Open:38.22

Low:38.01

Close:37.88

52wk High:41.49

52wk Low:22.33

Shares:6.75M

Float Shares:6.75M

Volume Ratio:0.62

T/O Rate:1.69%

Dividend:0.28

Dividend Rate:0.74%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Incyte Reaches CMS Pact on Jakafi Medicaid Pricing

NeuroThera Labs Advances Enrollment in Autism Drug Trial for SCI-210

Incyte - Expects Exemption from Future CMS Pricing Mandates Including Guard and Globe - SEC Filing

THOMSON REUTERS

Incyte - Announces Agreement with CMS to Improve Medicine Access - SEC Filing

THOMSON REUTERS

Incyte - State Medicaid to Access Jakafi and Jakafi Xr at Prices Aligned with Advanced Nations - SEC Filing

THOMSON REUTERS

Incyte - Does not Expect Agreement to Affect 2026 Financial Guidance or Outlook - SEC Filing

THOMSON REUTERS

SciSparc subsidiary provides update on SCI-210 trial enrollment

PMV Pharmaceuticals announces updated ovarian cancer data from PYNNACLE trial

Cboe data suggests bullish flow in Moderna with shares up 0.71%

Moderna Stock (MRNA) Was the Best Performer in August

Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240

THOMSON REUTERS

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Tenax Therapeutics announces results from Phase 3 LEVEL trial of TNX-103

Incyte (INCY) Stock Could Be 31% Stretched Following KRAS Data Buzz

Simply Wall St.

August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

US FDA Approves Takeda, Protagonist's Drug for Rare Blood Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/IDNA/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":38.06,"timestamp":1789156800000,"preClose":37.88,"halted":0,"volume":114363,"hourTrading":{"tag":"盘前","latestPrice":38.0843,"preClose":38.06,"latestTime":"07:15 EDT","volume":18,"amount":685.5174,"timestamp":1789384521291,"change":0.0243,"changeRate":0.000638,"amplitude":0},"delay":0,"changeRate":0.004751847940865884,"floatShares":6750000,"shares":6750000,"eps":0,"marketStatus":"Pre-Mkt","change":0.18,"latestTime":"09-14 07:35:27 EDT","open":38.22,"high":38.28,"low":38.005,"amount":4356036.121553999,"amplitude":0.00726,"askPrice":43.65,"askSize":100,"bidPrice":34.66,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":38.06,"sharesOutstanding":5100000,"nav":37.991633,"aum":258343104.4,"dividendRate":0.007399,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":38.0843,"preClose":38.06,"latestTime":"07:15 EDT","volume":18,"amount":685.5174,"timestamp":1789384521291,"change":0.0243,"changeRate":0.000638,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":38.06,"preClose":38.06,"latestTime":"19:30 EDT","volume":20,"amount":761.1742,"timestamp":1789169407146,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6184424703621776,"impliedVol":0.1978,"impliedVolPercentile":0.516},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6184424703621776,"shares":6750000,"dividePrice":0.2816,"high":38.28,"amplitude":0.00726,"preClose":37.88,"low":38.005,"week52Low":22.33,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":38.06,"eps":0,"divideRate":0.007399,"volume":114363,"delay":0,"ttmEps":0,"open":38.22,"prevYearClose":26.19,"prevWeekClose":38.06,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":40.29,"twentyDayClose":35.24,"sixtyDayClose":29.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664883783","title":"Incyte Reaches CMS Pact on Jakafi Medicaid Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883783","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883783?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:47","pubTimestamp":1788209252,"startTime":"0","endTime":"0","summary":"An announcement from Incyte ( ($INCY) ) is now available. Incyte Corporation said it has entered into an agreement with the U.S. Centers for Medica...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4532","BK4585","BK4550","IDNA","BK4139","INCY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883188","title":"NeuroThera Labs Advances Enrollment in Autism Drug Trial for SCI-210","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883188?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:37","pubTimestamp":1788208671,"startTime":"0","endTime":"0","summary":"NeuroThera Labs Inc. ( ($TSE:NTLX) ) has issued an update. NeuroThera Labs reported strong enrollment momentum in its SCI-210 clinical trial for ch...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-advances-enrollment-in-autism-drug-trial-for-sci-210?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-advances-enrollment-in-autism-drug-trial-for-sci-210?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","GDOC","MEDX","NVIB","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883375","title":"Incyte - Expects Exemption from Future CMS Pricing Mandates Including Guard and Globe - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883375?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4139","BK4585","IDNA","INCY","BK4588","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883311","title":"Incyte - Announces Agreement with CMS to Improve Medicine Access - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883311","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883311?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4532","BK4550","BK4139","INCY","BK4588","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883310","title":"Incyte - State Medicaid to Access Jakafi and Jakafi Xr at Prices Aligned with Advanced Nations - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883310?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","IDNA","BK4139","BK4585","BK4532","INCY","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664314883","title":"Incyte - Does not Expect Agreement to Affect 2026 Financial Guidance or Outlook - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664314883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664314883?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4550","INCY","BK4139","BK4532","IDNA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883858","title":"SciSparc subsidiary provides update on SCI-210 trial enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883858","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883858?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:10","pubTimestamp":1788207046,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC)announced that NeuroThera Labs continued advancement in participant enrollment for the clinical trial assessing NeuroThera’s SCI-210...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-subsidiary-provides-update-on-sci-210-trial-enrollment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-subsidiary-provides-update-on-sci-210-trial-enrollment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","IDNA","SPRC","MEDX","HYLG","BK4007","GDOC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831883","title":"PMV Pharmaceuticals announces updated ovarian cancer data from PYNNACLE trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831883","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831883?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:05","pubTimestamp":1788206710,"startTime":"0","endTime":"0","summary":"PMV Pharmaceuticals (PMVP) announced updated interim ovarian cancer data from the Phase 2 pivotal portion of the PYNNACLE clinical trial. The multi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pmv-pharmaceuticals-announces-updated-ovarian-cancer-data-from-pynnacle-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pmv-pharmaceuticals-announces-updated-ovarian-cancer-data-from-pynnacle-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NVIB","MEDX","IDNA","GDOC","PMVP","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000652","title":"Cboe data suggests bullish flow in Moderna with shares up 0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000652?lang=en_us&edition=fundamental","pubTime":"2026-09-01 02:20","pubTimestamp":1788200410,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Moderna (MRNA), with shares up 98c, or 0.71%, near $138.97. Options volume relatively light with 62k contracts t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-moderna-with-shares-up-0-71-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-moderna-with-shares-up-0-71-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4532","BK4139","GNOM","BK4548","MRNY","BK4501","MRNA","BK4588","IDNA","BK4551","MRNX","WDNA","BK4568","BK4533","LGHT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664200767","title":"Moderna Stock (MRNA) Was the Best Performer in August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664200767","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664200767?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:18","pubTimestamp":1788196728,"startTime":"0","endTime":"0","summary":"Moderna’s ($MRNA) stock rose 152% in August, making it the best-performing security during the month.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/moderna-stock-mrna-was-the-best-performer-in-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/moderna-stock-mrna-was-the-best-performer-in-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4501","MRNY","BK4551","LGHT","MRNX","BK4532","BK4533","BK4139","BK4568","BK4548","GNOM","IDNA","BK4585","MRNA","BK4534","BK4588","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079265","title":"Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079265?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:45","pubTimestamp":1788169510,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S00C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0002141913.USD","CANC","BK4139","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IDNA","IE0009354923.USD","LU0320765992.SGD","LU0889565916.HKD","RVMD","PTH","IE00BJJMRZ35.SGD","LU0109394709.USD","BBH","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","IYH","GDOC","BK4007","MRNY","LFSC","BMED","MRNX","TAK","BK4139","SYNB","RSPH","BBP","TBXU","IDNA","BK4585","NVIB","BK4588","FRTY","XLVX","LABU","PSCH","TECB","PINK","IBB","IEIH","MEDI","PTGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663404203","title":"Tenax Therapeutics announces results from Phase 3 LEVEL trial of TNX-103","url":"https://stock-news.laohu8.com/highlight/detail?id=2663404203","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663404203?lang=en_us&edition=fundamental","pubTime":"2026-08-31 03:35","pubTimestamp":1788118510,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics (TENX) announced that additional results from the Phase 3 LEVEL clinical trial evaluating TNX-103 in patients with pulmonary hyp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-announces-results-from-phase-3-level-trial-of-tnx-103-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-announces-results-from-phase-3-level-trial-of-tnx-103-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","NVIB","HYLG","BK4139","IDNA","BK4007","LENZ","MEDX","BK4539","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663562049","title":"Incyte (INCY) Stock Could Be 31% Stretched Following KRAS Data Buzz","url":"https://stock-news.laohu8.com/highlight/detail?id=2663562049","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663562049?lang=en_us&edition=fundamental","pubTime":"2026-08-30 15:21","pubTimestamp":1788074461,"startTime":"0","endTime":"0","summary":"Incyte stock has delivered a strong 92.3% gain over the past three years, yet current valuation checks suggest investors may be paying a premium to the intrinsic value estimate while traditional multiples look more in line with peers. The result is a stock that no longer looks obviously cheap, even after a solid multi year run.\n\nIncyte has returned 92.3% over three years, which puts more pressure on today’s valuation to be supported by future cash flows rather than past share price...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-stock-could-be-31-stretched-following-kras-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-stock-could-be-31-stretched-following-kras-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4532","BK4550","BK4588","BK4585","SPHQ","DCF","INCY","BK4139","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177566071","title":"August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand","url":"https://stock-news.laohu8.com/highlight/detail?id=1177566071","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177566071?lang=en_us&edition=fundamental","pubTime":"2026-08-30 13:40","pubTimestamp":1788068423,"startTime":"0","endTime":"0","summary":"August was expected to be a quiet month for markets, yet it has instead become a profound release of policy signals.US Treasury Secretary Scott Bessent has intervened in both the dollar-yen exchange...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLG","LU1066051498.USD","HK0000304797.USD","IE00BMPRXQ63.HKD","LU1992135472.HKD","LU1400636574.HKD","LU0175139822.USD","LU1804176565.USD","LU0289739343.SGD","LU2462591350.SGD","EFIV","LU0267386448.USD","SOXQ","LU1935042991.SGD","LU1551013342.USD","LFGY","LU1861220033.SGD","LU0795875086.SGD","LU2290526834.HKD","LU2543165471.USD","SG9999001424.SGD","METV","LU0823434740.USD","07788","LU1323610961.USD","LU0143551892.USD","LU1868836757.USD","NVYY","LU2272731600.USD","LU2491049909.HKD","LU1839511570.USD","THMR","LU0158827948.USD","LU1732800096.USD","BK4527","LU0942090050.USD","BK4588","LU0787776722.HKD","HK0000320264.USD","HK0000306685.HKD","DIPS","IE00BDRTCR15.USD","LU2746668974.SGD","LU0823434583.USD","BK4501","LU2265009873.SGD","LU2125909247.SGD","LU0289960550.SGD","LU2065170008.USD","LU1119994496.HKD","LU2242649171.HKD","LU2237443622.USD","IE00B19Z8X17.USD","SGXZ23171101.USD","SPTE","CMAG","LU0511384066.AUD","IE00BKVL7J92.USD","LU1861215975.USD","LU1988902786.USD","NVC","SG9999014567.USD","TTXU","SNVDAmain","IE0001KFT4U8.USD","LU1571399168.USD","SMHX","LU1037948897.HKD","LU1815336760.USD","LU2360032135.SGD","LU2168564222.USD","LU2168564495.EUR","LU0868494708.USD","LU2746668461.USD","LU0957791311.USD","LU2756315664.SGD","SG9999004303.SGD","HK0000304805.HKD","BK4581","LU2065171311.SGD","LU2347655156.SGD","LU2023250330.USD","LU0868494617.USD","LU1069347547.HKD","IE00B19Z8W00.USD","LU0251132253.USD","LU1934455863.HKD","NVDA","LU0390134368.USD","HK0000914686.HKD","LU1316542783.SGD","SG9999014880.SGD","LU0061475181.USD","LU1116320737.USD","LU1232071149.USD","ANV","SGXZ51526630.SGD","LU0353189763.USD","LU2111349929.HKD","LU0354030511.USD","LU0342679015.USD","LU0957808578.USD","BK4592","LU0345770308.USD","LGHT","LU0081259029.USD","LU2361045086.USD","LU0642271901.SGD","LU2471134523.USD","LU2491050154.USD","LU2458330169.SGD","LU0316494557.USD","TEK","LU1935043536.SGD","LU2264538146.SGD","LU0096362180.USD","LU1934455277.USD","LU2089284900.SGD","LU2347655073.USD","GAMR","IE00BQXX3C00.GBP","LU1917777945.USD","LU2430703095.HKD","CHPX","LU1084165304.USD","LU2403377893.USD","HK0000532082.HKD","LU1623119135.USD","IE00BQXX3D17.EUR","LU0029864427.USD","NVDX","LU2244417387.USD","IE00BJLML261.HKD","VGT","07388","LU1868837136.USD","LU1989764664.SGD","BK4551","NVIW.SI","BK4614","LU0320765059.SGD","LU0127658192.USD","LU2602419157.SGD","LU2168563687.JPY","LU0238689110.USD","ILDR","LU1496350171.SGD","LU2213496289.HKD","NULC","LU1935042488.USD","LU0345769128.USD","SGXZ81514606.USD","LU0061474960.USD","BK4608","NVDD","LU1145028129.USD","LU2394011477.USD","TYLG","LU2054465674.USD","IXN","FTEC","IGV","NVDU","LU2125909916.SGD","LU0077335932.USD","LU0719512351.SGD","LU0265550946.USD","LU0211328371.USD","SGXZ99366536.SGD","IE00BD6J9T35.USD","LU0724617625.USD","LU1400636657.SGD","LU2023251221.USD","MRNY","HK0000914660.USD","LU0072462426.USD","LU1923622291.USD","SGXZ80539844.SGD","SG9999014906.USD","IE0003U64NQ7.SGD","IE0034235188.USD","LU1983260115.SGD","LU2360106780.USD","LU1366192091.USD","NVDG","IETC","LU2237443978.SGD","LU1861127337.USD","LU2462591277.SGD","LU2458330243.SGD","LU0057025933.USD","LU2065169927.USD","NVDW","IE00BFSS7M15.SGD","NVDS.UK","LU0256863811.USD","IE0009G5SDU7.USD","IE00B1XK9C88.USD","SG9999018857.SGD","ROM","LU0494093205.USD","LU1280957306.USD","IE00BJJMRX11.SGD","SMH","LU2750360641.GBP","SG9999015952.SGD","LU0689626769.HKD","SG9999015986.USD","IE000YTNTUN2.SGD","BK4503","IE000Q6AESB8.SGD","LU1066051225.USD","IE00B775H168.HKD","LU2286300806.USD","LU1852331112.SGD","TRFK","LU1153585028.USD","LU1242518931.SGD","LU0154236417.USD","BK4554","NVD3.UK","LU2168564149.EUR","NVII","BK4533","LU2272731782.SGD","LU2473716301.USD","NVD2.UK","LU0820561818.USD","LU1366333091.USD","LU0912757837.SGD","LU1037948541.HKD","LU0211327993.USD","LU0820562030.AUD","IE00B4YYXB79.USD","LU2860962120.EUR","NVDB","IE000ITXATA3.USD","LU1934455194.USD","IE00BQXX3F31.USD","SG9999014898.SGD","LU2322448957.HKD","SGXZ31699556.SGD","LU0726765562.USD","LU2357305700.SGD","LU1642822529.SGD","LU0345768740.USD","LU1674673428.USD","LU0965509101.SGD","LU0225283273.USD","AIFD","LU0274383776.USD","LU1035773651.USD","LU2420271590.USD","LU2361044949.HKD","LU1267930573.SGD","IE0004086264.USD","LU1202635105.USD","LU0820561909.HKD","LU0738911758.USD","BK4529","NVDQ","SG9999015945.SGD","IE00BHPRN162.USD","LU1629891620.HKD","LU0080751232.USD","LU2125909759.SGD","LU1720051017.SGD","BK4567","IE00BMPRXN33.USD","LU0096364046.USD","LU2487616109.SGD","LU2100268510.USD","LU1814569148.SGD","IE00B5949003.HKD","LU2271345857.HKD","LU1242518857.USD","LU0444973449.USD","LU1267930490.SGD","LU0323591593.USD","LU2463028550.USD","HK0000306701.USD","LU0965509010.AUD","LU2168564065.EUR","LU2097344431.USD","LU1670756490.USD","LU0417517546.SGD","LU0011850046.USD","SG9999002232.USD","LU2430703178.SGD","LU1989772923.USD","LU2506951792.HKD","LU0353189680.USD","LU2505996681.GBP","LU0348723411.USD","LU0109391861.USD","IE00B5TLWC47.USD","BK4548","LU0061474705.USD","LU0661504455.SGD","LU0187121727.USD","IE00B3S45H60.SGD","LU1261432733.SGD","LU1267930730.SGD","LU0708995401.HKD","IE00BFSS8Q28.SGD","LU2211815571.USD","MRNA","SG9999014914.USD","LU1979441026.SGD","LU1244550221.USD","IE0034235303.USD","LU2237443465.HKD","JGRO","LU0266013472.USD","NVDS","XLK","LU2637965513.SGD","SG9999015341.SGD","LU2756315318.SGD","LU1691799644.USD","BK4585","LU0158827781.USD","ESUM","LU0256863902.USD","BK4612","LU0006306889.USD","LU0138981039.USD","SOXX","LU0048584097.USD","LU0070217475.USD","LU0310799852.SGD","BK4587","LU0964807845.USD","SG9999015978.USD","LU1674673691.USD","LU2023250504.SGD","LU1699723380.USD","LU2106854487.HKD","LU1880398554.USD","LU1923623000.USD","IE0004445239.USD","LU0640476718.USD","LU1791710582.SGD","LU1989772840.SGD","LU2471134952.CNY","IE00BJJMRY28.SGD","LU0689472784.USD","IE00B3SWFQ91.USD","LU2361044865.SGD","LU0943347566.SGD","SG9999014559.SGD","LU1066051811.HKD","LU0476273544.USD","LU2322448791.USD","LU2125154935.USD","LU1720051108.HKD","LU2237443549.SGD","LU0094547139.USD","LU0823421333.USD","LU1732799900.SGD","LU0795875169.SGD","LU0985320562.USD","LU2357125470.USD","LU2552382132.HKD","LU0466842654.USD","LU1712237335.SGD","IDNA","LU1951198990.SGD","BK4605","LU2191332357.HKD","LU2505996509.AUD","SG9999002224.SGD","LU2065171402.SGD","LU1244550494.USD","LU1064131342.USD","LU2249611893.SGD","TTEQ","LU0965508806.USD","SHOC","LU0823421416.USD","LU0198837287.USD","LU0234570918.USD","LU1144417596.USD","LU2237443382.USD","LU1429558221.USD","BK4534","LU2250418816.HKD","IE0004091025.USD","IE000KEQY171.SGD","LU0203202063.USD","LU2417539215.USD","IE00BDCRKT87.USD","SG9999017495.SGD","LU2279689827.SGD","BK4139","LU0861579265.USD","FDTX","SG9999015358.SGD","IE00BK4W5M84.HKD","LU2456880835.USD","LU0234572021.USD","LU0786609619.USD","LU0107464264.USD","LU0683600562.USD","LU2750360997.AUD","ABFL","LU1551013425.SGD","WISE","LU1496350502.SGD","LU0210528500.USD","LU2125909593.SGD","LU0203201768.USD","LU0053666078.USD","LU0276348264.USD","NVDY","IE00BZ1G4Q59.USD","LU2242650005.HKD","LU0174119429.USD","LU2087621335.USD","BK4579","IE0009356076.USD","LU1821325948.USD","2NVD.UK","LU1244550577.SGD","WDNA","LU2089283258.USD","AIPI","FAI","LU3102509885.SGD","LU0210533765.USD","IE00BMPRXR70.SGD","IE00BJTD4N35.SGD","LU0672654240.SGD","GNOM","LU2237957902.USD","LU2077746001.SGD","LU1951200564.SGD","LU2108987350.USD","SG9999000418.SGD","LU1633808545.USD","SNVD.UK","LU1923622614.USD","LU2326559502.SGD","LU0310800379.SGD","LU0079474960.USD","LU1803068979.SGD","LU0124676726.USD","LU1935042215.USD","BK4568","IE00B775SV38.USD","LU2133065610.SGD","LU0345770993.USD","LU0157215616.USD","LU0308772762.SGD","LU0882574139.USD","NVD","LU0965509283.SGD","IE000W1ABFV2.USD","SNPE","LU0210536198.USD","LU2063271972.USD","SG9999014575.USD","LU2237443895.HKD","LU2552382215.SGD","LU1645745479.HKD","LU1791710400.SGD","LU0069063385.USD","LU2237957811.SGD","LU2236285917.USD","LU1003077747.HKD","LU2148611432.USD","IE00BKDWB100.SGD","IE00BYXW3230.USD","LU2999663052.SGD","LU0056508442.USD","LU1035775433.USD","USXF","LU0170899867.USD","LU1935043023.USD","LU2047632596.USD","LU0082616367.USD","LU0323239441.USD","LU2471134796.USD","LU2433249047.HKD","LU2125154778.USD","IE0004445015.USD","LU0979878070.USD","SOXY","NVDO","LU2452424414.USD","IE0005OL40V9.USD","LU0289961442.SGD","LU0545039389.USD","VT","3NVD.UK","LU0557290698.USD","IE00B3M56506.USD","IE00B19Z9505.USD","LU1069344957.HKD","LU2471134879.HKD","SG9999018865.SGD","LU2092627202.USD","LU2272731865.HKD","LU2413666426.HKD","LU2491050071.SGD","MRNX","LU1066053197.SGD","SG9999014542.SGD","LU0345769631.USD","LU2592432038.USD","LU2552382058.USD","LU0528227936.USD","BK4141","LU1116320901.HKD","LU0347712357.USD","BK4550","LU2931357623.SGD","LU0109392836.USD","BK4598","LU0395794307.EUR","LU2294711713.HKD","HK0000819398.USD","LU1127390331.HKD","LU2430703251.USD","IE00BN29S564.USD","LU0788109477.HKD","LU2237438978.USD","LU1868837300.USD","BK4532","CNEQ","LU0823414551.USD","LU2954938101.SGD","LU2247934214.USD","LU1400636491.USD","LU2462157665.USD","LU0215105999.USD","LU1868836591.USD","LU0106261372.USD","IE00BJTD4V19.USD","IE00B7KXQ091.USD","LU0265550359.USD","LU0472753341.HKD","AGOX","LU0553294199.USD","BK4549","LU2461242641.AUD","LU0133085943.USD","GB00BDT5M118.USD","IE00BZ199S13.USD","LU1721428933.USD","LU1435385759.SGD","LU0444971666.USD","LU1914381329.SGD","CLSE","LU1718418525.SGD","NVDL","IE0034235295.USD","LU0823414478.USD","LU0889565833.HKD","LU1880398471.USD","LU2381873111.SGD","LU0128525929.USD","HK0000320223.HKD","LU0345768153.USD","BK4543","LU2028103732.USD","LU2083900584.USD","LU2097344357.USD","LU1778281490.HKD","LU0949170772.SGD","IE00B1BXHZ80.USD","LU2896262040.SGD","LU2089985449.USD","LU0323240290.USD","LU1974910355.USD","LU1548497426.USD","USD","LU1815333072.USD","LU2092937148.SGD","LU1989764748.USD","LU1992135399.USD","IE00BK4W5L77.USD","LU1868836914.USD","LU2413666699.HKD","LU2360107168.USD","IE00BWXC8680.SGD","LU2087625088.SGD","LU0097036916.USD","IE00B4JS1V06.HKD","LU0708994859.HKD","IE00BKPKM429.USD","LU0354030438.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663464017","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663464017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663464017?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:30","pubTimestamp":1788013830,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Spyre Therapeutics (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","BK4137","IE0002141913.USD","IE0009355771.USD","LU0320765992.SGD","LABU","IDNA","LFSC","CANC","PTH","IE00BJT1NW94.SGD","LU0128526141.USD","IE00BJJMRZ35.SGD","HCSG","BK4581","XLV","XBI","SYRE","BBH","IE00B2B36J28.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","BK4585","LU0029874061.USD","RVMD","BK4588","IE0009354923.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019778","title":"Pharma Industry Stares Down Biggest Patent Cliff in Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019778?lang=en_us&edition=fundamental","pubTime":"2026-08-29 09:00","pubTimestamp":1787965200,"startTime":"0","endTime":"0","summary":"Most companies sell a hit product for as long as customers want it. For drugmakers, a clock starts before a drug is even approved: Patents run out, lower-priced copycats flood in and sales collapse. B","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BDGV0183.EUR","LU1585245621.USD","LU0069063385.USD","LU0511384066.AUD","IE0004445239.USD","GDOC","SG9999002232.USD","LU2750360997.AUD","LU2168564495.EUR","LU1883839398.USD","LU1236620834.HKD","LU1670710661.SGD","IE0005OL40V9.USD","LU0133085943.USD","LU1989772840.SGD","IE00BN29S564.USD","LU2133065610.SGD","IE00B2B36J28.USD","IE00BSNM7G36.USD","LU0265550359.USD","AGNG","LU0208291251.USD","LU1670628061.USD","LU0061475181.USD","LU2471134952.CNY","LU1720051017.SGD","LU1699723380.USD","LU2552382132.HKD","IE0004445015.USD","IE00BVYPNW00.USD","LU0225283273.USD","LU2089284900.SGD","LU0545039389.USD","LU0395794307.EUR","LU1551013425.SGD","LU2462591350.SGD","LU2129689514.USD","LU2461242641.AUD","LU1093756325.SGD","LU0985481810.HKD","IE00BFSS8Q28.SGD","LU0456855351.SGD","LU2125909247.SGD","LU0786609619.USD","LU0234572021.USD","LU1670710588.SGD","IE00BJJMRZ35.SGD","LU0203347892.USD","SGXZ51526630.SGD","LU0238689110.USD","LU2242652126.USD","LU0203345920.USD","SG9999014914.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU2746668461.USD","LU2125154935.USD","LU0889565916.HKD","NVO","LU1989771016.USD","IE00BFSS7M15.SGD","LU0211331839.USD","MEDX","LU0256863902.USD","LU0787776722.HKD","TRUH","LU1093756168.USD","LU1116320901.HKD","LU0354030438.USD","JDOC","LU2896262040.SGD","LU0321505439.SGD","SG9999018857.SGD","LU1244550577.SGD","LU2746668974.SGD","SG9999001176.SGD","LU1035773651.USD","LU0823434583.USD","LU2237443895.HKD","LU1941712348.USD","OZEM","LU1267930730.SGD","LU1280957306.USD","SGXZ81514606.USD","IE00B1XK9C88.USD","HRTS","LU0198837287.USD","SG9999014898.SGD","LU2360106947.USD","LU2028103732.USD","LU2168563687.JPY","IE00BZ1G4Q59.USD","LU0708995401.HKD","LU2361044865.SGD","LU2324357040.USD","LU0965508806.USD","LU0466842654.USD","IE00BWXC8680.SGD","LU1069344957.HKD","LU0980610538.SGD","BK4588","LU0353189680.USD","LU1917777945.USD","WDNA","MRNY","LGHT","LU0323591593.USD","IE00BN8TJ469.HKD","ILDR","LU0320765646.SGD","LU0820561818.USD","LU2491050154.USD","GLAM","IE000SO60NU8.SGD","LU2471134796.USD","LU2023250843.SGD","LU1670711123.USD","LU2129689431.USD","LU2242646821.SGD","LU2471134879.HKD","LU2213496289.HKD","LU0949170772.SGD","LU2168564222.USD","LU0354030511.USD","LU2456880835.USD","LU0965509010.AUD","LU2211815571.USD","LU2265009873.SGD","LU2089283258.USD","LU0320765059.SGD","LU1032466523.USD","LU1064131342.USD","LU2125154778.USD","LU1670711040.USD","IE000F7OJYX1.SGD","LU1868837136.USD","LU0640476718.USD","LU2237438978.USD","LU1066051811.HKD","LU2417539215.USD","LU0266013472.USD","IE00B3PB1722.GBP","LU2357627491.SGD","GB00BDT5M118.USD","LU0203201768.USD","LU2360032135.SGD","SG9999014575.USD","LU2468319806.SGD","GNOM","LU2087621335.USD","LU1974910355.USD","LU2596442595.SGD","LU1691799644.USD","LU2462157665.USD","SG9999001176.USD","LU0432979614.USD","LU1988902786.USD","LU0130102774.USD","LU1571399168.USD","LU1629891620.HKD","LU1923622614.USD","LU0964807845.USD","IE000BZT7R73.USD","LU1057294990.SGD","LU1061106388.HKD","LU1551013342.USD","LU0154236417.USD","LU0320765489.SGD","RVMD","LU0203202063.USD","IE00B4R5TH58.HKD","BMED","LU0114720955.EUR","LU2112291526.USD","LU0225771236.USD","IDNA","LU2552382058.USD","LU2357305700.SGD","LU2237443978.SGD","LU0006306889.USD","SGXZ99366536.SGD","BK4533","LU2168564149.EUR","LU0234570918.USD","IE0002270589.USD","IE00BFXG1179.USD","IE000M9KFDE8.USD","PTH","VHT","LU1868836914.USD","LU1003077747.HKD","LU1035775433.USD","LU0170899867.USD","LU0211328371.USD","LU0965509283.SGD","SG9999015978.USD","LU2129689605.HKD","LU0689472784.USD","IE0009355771.USD","LU2756315664.SGD","LU1718418525.SGD","LU0823434740.USD","SG9999014559.SGD","LU0225284248.USD","FTXH","LU2750360641.GBP","LU0210536198.USD","LU2271345857.HKD","LU1670627923.USD","LU2756315318.SGD","BK4007","IYH","IE00B42XCP33.USD","LU0124676726.USD","ELIL","LU0320765992.SGD","IE00BJT1NW94.SGD","LU1496350502.SGD","NVOC","IE00BGHQF631.EUR","LU1236620750.USD","LU1712237335.SGD","BK4585","LU0648001328.SGD","SG9999003800.SGD","LU2236285917.USD","SG9999018865.SGD","LU0057025933.USD","LU0868494708.USD","LU2491049909.HKD","SGXZ31699556.SGD","SG9999015945.SGD","LU2237443465.HKD","LU2471134523.USD","LU0158827948.USD","LU2168564065.EUR","LU0726765562.USD","LU1074936037.SGD","LU0943347566.SGD","LU0096364046.USD","LU1201861249.SGD","LU2361045086.USD","BMY","IE00B1BXHZ80.USD","IE0009354923.USD","IE00B775H168.HKD","LU0070302665.USD","LU0106261372.USD","BK4599","LU2023251221.USD","LU2108987350.USD","LU0477156953.USD","LU1323610961.USD","LU1023059063.AUD","LU0306807586.USD","LLII","LU1261432733.SGD","LU0708994859.HKD","ABBV","SG9999015358.SGD","LU0289739699.SGD","LU0661504455.SGD","LU2433249047.HKD","BK4568","LU1868836757.USD","LU0683600562.USD","MRNA","LU0553294199.USD","LU0237698245.USD","BK4139","CURE","LU0265550946.USD","IHE","MEDI","LU0417517546.SGD","LU0820562030.AUD","LU0472753341.HKD","IE00BJLML261.HKD","BK4559","LU0912757837.SGD","LU2237443549.SGD","LLYX","BK4566","IE00BBT3K403.USD","IE00BK4W5L77.USD","BK4534","LU1127390331.HKD","LU0672654240.SGD","LU2237443622.USD","LU0795875169.SGD","LU1934455863.HKD","LU0058720904.USD","LU2089984988.USD","BBH","LU1839511570.USD","LU1983299246.USD","LU1804176565.USD","LU1814569148.SGD","IE00BLSP4239.USD","LU1430594728.SGD","LU1929549753.HKD","LU1066051225.USD","LU1623119135.USD","IE00BJJMRY28.SGD","LU0158827781.USD","LLYZ","BK4551","LU0861579265.USD","LU1934455194.USD","LU1979441026.SGD","LU1291159041.SGD","LU1366192091.USD","LU0353189763.USD","LU1941712264.USD","MRNX","SG9999002224.SGD","IE00BKPKM429.USD","LU1145028129.USD","LU0267386448.USD","LU0289739343.SGD","BK4581","NVOX","LU0316494557.USD","LU1069347547.HKD","LU0097036916.USD","LU2023250330.USD","LU0859254822.USD","LU1066053197.SGD","LU1244550221.USD","PJP","LU0130517989.USD","THNR","LU1244550494.USD","LU0868494617.USD","TMED","LU1037948897.HKD","BK4548","LU1066051498.USD","LU0882574139.USD","LU2552382215.SGD","LU0689626769.HKD","SG9999014567.USD","NVOH","FHLC","BK4550","LU2111349929.HKD","SG9999011175.SGD","LU1720051108.HKD","SG9999014542.SGD","LU2491050071.SGD","SG9999015952.SGD","LU0109394709.USD","IE00BLSP4452.SGD","LU0122379950.USD","LU1267930573.SGD","LU2361044949.HKD","IE00BJJMRX11.SGD","SG9999015341.SGD","LU1868836591.USD","SG9999013999.USD","IXJ","BK4532","SG9999017495.SGD","SGXZ57979304.SGD","IE000MB6IJN5.SGD","LU0820561909.HKD","MRK","BK4516","LU1732799900.SGD","LU0306806265.USD","SG9999001440.SGD","LU1548497426.USD","LU2063271972.USD","LU0079474960.USD","IE00B4JS1V06.HKD","LU0738911758.USD","LU0109391861.USD","LU0795875086.SGD","LU0471298694.HKD","LU1232071149.USD","IE00B19Z3B42.SGD","LU0098860793.USD","LU2602419157.SGD","IE0000B7K699.USD","SG9999014906.USD","IE0001KFT4U8.USD","LU0345770308.USD","LU0211327993.USD","LU1868837300.USD","LU0094547139.USD","PPH","LU2087625088.SGD","LU2264538146.SGD","LU2237443382.USD","XLV","CANC","LU0965509101.SGD","LU0321505868.SGD","LU2106854487.HKD","LU0310799852.SGD","LU0174119429.USD","LU0942090050.USD","LU1732800096.USD","IE00BK4W5M84.HKD","LU0385154629.USD","ELIS","LU2023250504.SGD","LU1162221912.USD","LU2347655073.USD","LU2125909593.SGD","PAWZ","LU1496350171.SGD","LU2347655156.SGD","IE00BKVL7J92.USD","MHIP","RXL","IE00BKDWB100.SGD","IE00B7KXQ091.USD","LU1116320737.USD","IE00BVYPNV92.GBP","SG9999015986.USD","LU0256863811.USD","LU0310800379.SGD","LU0029864427.USD","SG9999014880.SGD","IE00B19Z3581.USD","LU0985320562.USD","LU1037948541.HKD","LU0471298777.SGD","LLY","LU1267930490.SGD","LU0823416689.USD","LU1934455277.USD","IE000WAW04H5.SGD","LU0128525929.USD","BK4501","LU0882574055.USD","LU1989772923.USD","LU0345770993.USD","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVIB","MRNX","BMED","IBB","TECB","TBXU","MEDI","RSPH","LFSC","PSCH","FRTY","IEIH","PINK","BK4588","GDOC","IYH","XLVX","SYNB","IDNA","MRNY","GNMX","LABU","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","NVIB","SYNB","BMED","GDOC","LFSC","TECB","IYH","PINK","GNMX","FRTY","IBB","RSPH","BBP","PSCH","MRNY","TBXU","MRNX","TAK","BK4007","BK4585","MEDI","IDNA","LABU","IEIH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663201572","title":"US FDA Approves Takeda, Protagonist's Drug for Rare Blood Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2663201572","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663201572?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:37","pubTimestamp":1787953064,"startTime":"0","endTime":"0","summary":"US FDA approves Takeda, Protagonist's drug for rare blood cancerAug 28 (Reuters)-The U.S. Food and Drug Administration hasapproveda first-of-its-kind drug from Takeda Pharmaceutical4502.Tand Protagonist TherapeuticsPTGX.Oto treat a rare blood cancer,the health regulator said on Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P1MY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4550","INCY","BK4139","BK4532","PTGX","BK4585","IDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}